Oruka Therapeutics, Inc.ORKAEarnings & Financial Report
Nasdaq
NextFeb 18, 2026
ORKA Q2 2024 Key Financial Metrics
Revenue
$0
Gross Profit
N/A
Operating Profit
$-3.1M
Net Profit
$-2.7M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
EPS
$-0.18
Oruka Therapeutics, Inc. Q2 2024 Financial Summary
Oruka Therapeutics, Inc. reported revenue of $0 for Q2 2024, with a net profit of $-2.7M (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $0 |
|---|---|
| Net Profit | $-2.7M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q2 2024 |
Oruka Therapeutics, Inc. Annual Revenue by Year
Oruka Therapeutics, Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $0).
| Year | Annual Revenue |
|---|---|
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Balance Sheet
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $45.0M | $43.1M | $42.1M | $41.1M | $39.2M | $37.9M | $36.7M | $33.8M |
| Liabilities | $2.2M | $1.4M | $1.5M | $1.8M | $1.2M | $841000 | $1.6M | $1.3M |
| Equity | $42.7M | $41.7M | $40.5M | $39.2M | $38.0M | $37.0M | $35.1M | $32.6M |
Cash Flow
| Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-2.5M | $-1.5M | $-1.6M | $-694000 | $-1.7M | $-1.1M | $-1.5M | $-2.6M |